You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pancreatic adenocarcinoma

Showing 26 - 50 of 6,047
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Improving Pancreatic Cancer Care by Use of Computational Science

Recruiting
  • Pancreatic Cancer
  • +5 more
  • No interventions
  • Utrecht, Netherlands
    Regional Academic Cancer Center Utrecht
Sep 22, 2023

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Fluorodeoxyglucose F18 Trial in Ghent (Positron Emissie Tomografie - Computer Tomografie)

Recruiting
  • Fluorodeoxyglucose F18
  • Positron Emissie Tomografie - Computer Tomografie
  • Ghent, East-flanders, Belgium
    University Hospital Ghent
Jan 16, 2023

Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

Recruiting
  • Hepatocarcinoma
  • Pancreatic Tumor
  • Hepatocellular carcinoma
  • +2 more
  • Clichy, France
    Hôpital Beaujon
Mar 20, 2023

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Survival, Quality of Life and Resectability in Locally Advanced

Recruiting
  • Pancreas Cancer
  • +8 more
    • Umeå, Sweden
      Surgical Clinic at Umeå University Hospital
    Nov 23, 2022

    Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • mFOLFIRINOX plus radiotherapy
    • (no location specified)
    Nov 21, 2023

    Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in Houston (Autologous DC vaccine)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Cancer
    • Autologous DC vaccine
    • Houston, Texas
    • +2 more
    Aug 17, 2022

    The HELPP Score: A Pretreatment Score to Predict Survival in

    Not yet recruiting
    • Pancreatic Adenocarcinoma
      • Vienna, Austria
        Department of General Surgery, Division of Visceral Surgery, Med
      Feb 21, 2023

      Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Aug 15, 2022

      Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

      Not yet recruiting
      • Pancreatic Cancer
      • Shanghai, Shanghai, China
        Department of Pancreatic Surgery, Fudan University Shanghai Canc
      Dec 4, 2023

      Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +3 more
      • Cholesterol metabolism disruption
      • Quebec city, Quebec, Canada
        CHU de Québec-Université Laval
      Oct 17, 2022

      Pancreas Cancer Trial in Cincinnati (drug, radiation, procedure)

      Recruiting
      • Pancreas Cancer
      • Tucson, Arizona
      • +1 more
      Sep 13, 2022

      Surgery After Neoadjuvant Chemotherapy in Locally Advanced

      Completed
      • Postoperative Complications
      • surgery after neoadjuvant chemotherapy
      • Seoul, Korea, Republic of
        Asan medical center
      Jun 1, 2023

      Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

      Not yet recruiting
      • Pancreatic Cancer
      • +3 more
      • Boston, Massachusetts
      • +1 more
      Sep 16, 2022

      Pancreatic Cancer Trial (Rintatolimod)

      Not yet recruiting
      • Pancreatic Cancer
      • (no location specified)
      Aug 8, 2022

      Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

      Not yet recruiting
      • Pancreatic Adenocarcinoma Metastatic
        • Pessac, France
          CHU Bordeaux
        Aug 17, 2023

        Resected Pancreatic Adenocarcinoma

        Completed
        • Pancreatic Cancer Resectable
        • Multigene panel for next-generation sequencing
        • Shanghai, Shanghai, China
          Ruijin Hospital
        Jul 31, 2022

        Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

        Terminated
        Has Results
        • Pancreatic Adenocarcinoma
        • +2 more
        • Pembrolizumab
        • Wild-type Reovirus
        • Chicago, Illinois
          Northwestern University
        Sep 6, 2022

        Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

        Recruiting
        • Metastatic Pancreatic Adenocarcinoma
        • Shanghai, Shanghai, China
          Shanghai Cancer Center
        Aug 29, 2023

        Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

        Recruiting
        • Colorectal Cancer
        • Pancreatic Adenocarcinoma
        • Singapore, Singapore
          National Cancer Centre
        Jun 10, 2022

        Resectable or Locally Advanced Borderline Pancreatic

        Active, not recruiting
        • Pancreas Cancer
        • Adenocarcinoma
          • Paris, France
            Groupe Hospitalier Paris Saint-Joseph
          Aug 19, 2022

          Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

          Not yet recruiting
          • Gastric Cancer
          • +3 more
          • LB1908
          • (no location specified)
          Sep 9, 2022

          Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

          Not yet recruiting
          • Metastatic Pancreatic Adenocarcinoma
          • Ann Arbor, Michigan
            Rogel Cancer Center
          Jun 26, 2023

          Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable

          Not yet recruiting
          • Locally Advanced Pancreatic Adenocarcinoma
          • +2 more
          • Biospecimen Collection
          • +8 more
          • Los Angeles, California
            USC / Norris Comprehensive Cancer Center
          Nov 9, 2023